Preclinical study of safety and immunogenicity of combined rubella and human papillomavirus vaccines: Towards enhancing vaccination uptake rates in developing countries

Rubella vaccine was not part of national immunization programs (NIP) in several countries in the Middle East and North Africa (MENA), South-East Asia (SEA), and South Africa regions until the year 2000. Therefore, immunization coverage of females older than 20 years old in these countries has been t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gohar, Asmaa, Abdeltawab, Nourtan F., Shehata, Nahla, Amin, Magdy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586776/
https://www.ncbi.nlm.nih.gov/pubmed/31185296
http://dx.doi.org/10.1016/j.pvr.2019.100172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586776/
https://www.ncbi.nlm.nih.gov/pubmed/31185296
http://dx.doi.org/10.1016/j.pvr.2019.100172

Ejemplares similares